Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-13 06:05:14 EDT

Explore

PostsPeople
LatestRanked
Load more
@onclive.bsky.socialOct 2, 2026, 7:53 PM

🚨BREAKING: The @fda.gov has approved pirtobrutinib for adult patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma with no known 17p deletion #leusm #oncology

Read more: www.onclive.com/view/fda-app...

Photo, no description
@axs-studio.comOct 2, 2026, 6:16 PM

AXS Studio will be at #ESMO26 in Madrid this year! Come by booth 8075 to test your sci-viz knowledge and learn how AXS Studio’s expertise can help elevate your science story with stunning, data-backed visual solutions.

#oncology #cancerresearch #biotech #scicomm #biopharm #medtech

Photo, no descriptionPhoto, no descriptionPhoto, no description
@onclive.bsky.socialOct 2, 2026, 2:41 PM

🗞️ A @fda.gov NDA submission has been initiated for zipalertinib plus platinum-based chemotherapy in frontline, EGFR exon 20 insertion–positive NSCLC #lcsm #oncology

Dive into the REZILIENT3 data supporting the application: www.onclive.com/view/nda-sub...

Photo, no description
@canceropolegso.bsky.socialOct 2, 2026, 2:33 PM

💡 JGSO 2026

🎙️ Discover one of our keynotes for the 22nd Annual Meeting of the Cancéropôle Grand Sud-Ouest !

Find all information about the congress: kgso.fr/events/22nd-...

#JGSO #Oncology #CancerResearch

Photo, no description
@onclive.bsky.socialOct 2, 2026, 2:01 PM

Did you miss key updates in NSCLC, breast cancer, MDS, and PTLD? Test your knowledge with this week's OncLive news quiz #lcsm #bcsm #mpnsm #oncology

www.onclive.com/view/onclive...

@onclive.bsky.socialOct 2, 2026, 2:00 PM

Phase 2 and 3 data showed aglatimagene besadenovec plus EBRT was associated with improved prostate cancer–specific disease-free survival and evidence of sustained immune activity in intermediate-risk localized prostate cancer #pcsm #oncology

www.onclive.com/view/aglatim...

@gmj-georgia.bsky.socialOct 2, 2026, 9:26 AM

Machine learning is reshaping radiopharmaceutical cancer therapy. According to @JMIR, AI algorithms accelerate drug discovery … #Artificialintelligence #Drugdiscovery #Machinelearning #Oncology #Personalizeddosimetry #Artificialintelligence #Drugdiscovery #Machinelearning #Oncology #Personalize…

@thecancersurvivorsclub.comOct 2, 2026, 8:32 AM

Five major Phase 3 trials reported encouraging results in September, including advances in lung cancer and multiple myeloma and longer-term evidence for targeted treatment after lung cancer surgery.

www.curetoday.com/view/the-5-m...

#CancerResearch #ClinicalTrials #Oncology #TCSC

@westlakeu.bsky.socialOct 2, 2026, 8:03 AM

What’s next in the fight against cancer? Join leading scientists & clinicians from around the world at the Westlake x Cell Press Oncology Conference 2026.
📅 Date: Nov 6-8, 2026
📍 Venue: Westlake University, Hangzhou
👉 Register: https://bit.ly/4delXah

#WestlakeUniversity #WestlakeGlobal #Oncology

Photo, no description
@bcc2026.bsky.socialOct 2, 2026, 5:06 AM

Breast Cancer Congress 2027

June 17–18, 2027
Zurich, Switzerland

Connect with global experts in breast cancer research, clinical care, innovation, and healthcare.

pinkribboncongress.com

#BreastCancer #Oncology #CancerResearch #BreastCancer2027 #MedicalConference #BCC2027

Photo, no description
@drrichmd.bsky.socialOct 2, 2026, 4:08 AM

Healthy life line: Do routine self breast exams (SBE). Mammogram & Other Preventive Cancer Checkup Tests bit.ly/1zIvrCm amzn.to/13m51UU #health #wellness #HealthLiteracyMonth #BreastCancerAwarenessMonth #BreastCancer #oncology #HealthSky #MedSky #BookSky

@nextlogic-ai-pt.bsky.socialOct 2, 2026, 2:27 AM

🎨 Novo post: Nova Esperança no Câncer de Pâncreas: Como Daraxonrasibe Está Mudando o Jogo
#ai #biotech #oncology #LiderançaTecnológica #InovaçãoDigital

👇 Veja mais aqui:
https://nextlogic-ai.achlabo.com/pt/nova-esperanca-no-cancer-de-pancreas-como-daraxonrasibe-esta-mudando-o-jogo/

Nova Esperança no Câncer de Pâncreas: Como Daraxonrasibe Está Mudando o Jogo
@hemehub.bsky.socialOct 2, 2026, 12:40 AM

🩸Our case discussion on Smoldering Multiple Myeloma with Shaji Kumar, MD and Adeel Khan, MD is now available to watch on YouTube!

⮕ Watch the full session: youtu.be/vbFJmFe0vjE?...

#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub

Photo, no descriptionPhoto, no descriptionPhoto, no descriptionPhoto, no description
@onc-rg.bsky.socialOct 2, 2026, 12:07 AM

𝙏𝙝𝙚 2026 𝙀𝙎𝙈𝙊 𝙇𝘽𝘼 𝙇𝙖𝙣𝙙𝙨𝙘𝙖𝙥𝙚: 𝙑𝙞𝙨𝙪𝙖𝙡𝙞𝙯𝙚𝙙.
Which mechanisms are commanding the late-breaker spotlight this year?

#ESMO2026 #ESMO26 #Oncology #NSCLC #SCLC #ADCs #vaccines #ClinicalData #DrugTrials #CompetitiveStrategy

Our analysts crunched the numbers across all LBAs: ✔️ADCs lead the field — nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond ✔️Checkpoint inhibition isn't just a category — it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more ✔️Beyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO Stay ahead of the competitive curve with verified insights. Our analysts crunched the numbers across all LBAs: ✔️ADCs lead the field — nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond ✔️Checkpoint inhibition isn't just a category — it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more ✔️Beyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO Stay ahead of the competitive curve with verified insights.
@onclive.bsky.socialOct 1, 2026, 9:37 PM

🎙️ In case you missed any, read a recap of the episodes of #OncliveOnAir that aired in September 2026. @lpetrillz.bsky.social @matthewkurianmd.bsky.social #oncology #hematology

Read the full recap ➡️: www.onclive.com/view/revisit...

@onclive.bsky.socialOct 1, 2026, 8:35 PM

Pancreatic cancer treatment is expanding in Japan: The MHLW has approved Optune Pax for concomitant use with gemcitabine and nab-paclitaxel in unresectable locally advanced disease #pancsm #oncology

www.onclive.com/view/optune-...

@drtimos.bsky.socialOct 1, 2026, 6:05 PM

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TVkgfk !

#Oncology #SocialListening #LucidQuest

@onclive.bsky.socialOct 1, 2026, 2:54 PM

📰Topline data from the phase 3 portion of the AZTOUND trial showed oral azacitidine and cedazuridine met the pharmacokinetic primary end point in patients with MDS or CMML #mpnsm #leusm #oncology

Read more: www.onclive.com/view/oral-az...

@onclive.bsky.socialOct 1, 2026, 2:47 PM

👀 NXC-201, a sterically optimized BCMA-directed CAR T-cell therapy, produced a high response rates in R/R AL amyloidosis, according to an interim update from the phase 1b/2 NEXICART-2 trial.

Full details 📰: www.onclive.com/view/nxc-201...

#oncology #mmsm

@bd-angry.bsky.socialOct 1, 2026, 1:56 PM

#Radiotherapy #Diary Day 33 - brain buzzing complete! #Gratitude to #oncology #nurses
#Celebrate in #Bradford
Diarising 33 days’ radiotherapy, over 7 weeks, to treat my brain #cancer.

youtube.com/shorts/4ui9A...